Novosorb is the only artificial product on the market. A 10 cm square piece sells for $950 in the States and according to David costs around $30 to make. To manufacture similar product with animal content costs a lot more, i.e. Around $1,000, and sells for a lot more than NovaSorb. Also because of this animal content they often have over a 30% infection rate, plus the time in the operation theatre and the hospital is usually a lot less when using NovaSorb, and with less scaring, i.e. Better outcome. My question is how can the competitors compete?? I'll repeat what David said ... they have a revolutionary product.
The Clinicians Speak, page-976
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.57 |
Change
0.030(1.18%) |
Mkt cap ! $1.773B | |||
| Open | High | Low | Value | Volume |
| $2.60 | $2.60 | $2.55 | $1.327M | 514.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2507 | $2.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.58 | 4000 | 2 |
View Market Depth
| Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |